Ohcanbohtosat - Dapash, Mark

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma Dahkki Dapash, Mark, Castro, Brandyn, Hou, David, Lee-Chang, Catalina

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

The Interplay between Glioblastoma and Its Microenvironment Dahkki Dapash, Mark, Hou, David, Castro, Brandyn, Lee-Chang, Catalina, Lesniak, Maciej S.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Correlation of post-contrast T1-weighted MRI surface regularity, tumor bulk, and necrotic volume with Ki67 and p53 in glioblastomas Dahkki Hasse, Adam, Dapash, Mark, Jeong, Yong, Ansari, Sameer A., Carroll, Timothy J., Lesniak, Maciej, Ginat, Daniel Thomas

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

EXTH-29. DUAL TGFB AND PD1 BLOCKADE PROMOTES GERMINAL-CENTER B-CELL IMMUNE RESPONSES AGAINST GLIOBLASTOMA Dahkki Dapash, Mark, Hou, David, Castro, Brandyn, Rashidi, Aida, Zhang, Peng, Stupp, Roger, Miska, Jason, Lesniak, Maciej, Chang, Catalina

Viečča ollesdeavstta Viečča ollesdeavstta

IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8(+) MEMORY T CELLS Dahkki Hou, David, Castro, Brandyn, Dapash, Mark, Rashidi, Aida, Zhang, Peng, Han, Yu, Lopez-Rosas, Aurora, Lesniak, Maciej, Miska, Jason, Chang, Catalina

Viečča ollesdeavstta Viečča ollesdeavstta

TAMI-25. UPREGULATION OF CREATINE METABOLISM BY MYELOID CELLS RESULTS IN GLIOBLASTOMA PROGRESSION Dahkki Rashidi, Aida, Cordero, Alex, Castro, Brandyn, Hou, David, Dapash, Mark, Zhang, Peng, Han, Yu, Lopez-Rosas, Aurora, Chandel, Navdeep, Lesniak, Maciej, Chang, Catalina, Miska, Jason

Viečča ollesdeavstta Viečča ollesdeavstta